Walgreens and InComm Payments Announced Their Agreement
On March 30, Walgreens announced an agreement with InComm Payments, a leading global payments technology company, to provide convenient and accessible financial services options for…
March 2021
FDA Approves Abecma To Treat Multiple Myeloma
The U.S. Food and Drug Administration (FDA) approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not…
Moderna, Pfizer Vaccines For Pregnant And Lactating Women
On March 26, Contemporary OB/GYN Journal published an article about new research, that Moderna, Pfizer vaccines shown safe and effective in pregnant & lactating women.“Pregnant…
COVID-19 Vaccination at Dialysis Centers
A new federal effort announced on March 25, will help people with chronic kidney disease who require dialysis access COVID-19 vaccination at dialysis clinics, as…
FDA Warns Companies Illegally Selling CBD Products
The U.S. Food and Drug Administration (FDA) has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that…
Zealand Pharma Announces FDA Approval of Zegalogue (dasiglucagon)
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
AZD1222 US Phase III Trial
The AstraZeneca’s AZD1222 US Phase III Trial demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease…
Medicare Payment for COVID-19 Vaccination Increased
On March 15, the Centers for Medicare & Medicaid Services (CMS) is increasing the Medicare payment amount for administering the COVID-19 vaccine.“This new and higher…
$2.25 Billion to Address COVID-19 Health Disparities
The Centers for Disease Control and Prevention (CDC), on March 17, announced a plan to invest $2.25 billion over two years to address Coronavirus Disease…
FDA Permits Marketing of First SARS-CoV-2 Diagnostic Test
On March 17, the U.S. Food and Drug Administration (FDA) granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), the first SARS-CoV-2 diagnostic test…